Pre-registered substances

These pre-registration intentions were submitted to ECHA between 1 June and 1 December 2008. Use this list to find other potential registrants of your substance so that you can submit a registration dossier jointly, as required by REACH.

Database contains 145299 unique substances/entries.

Filter the list

Showing 1,451 - 1,500 of 145,299 results.

Name	EC / List no.	CAS no.	Envisaged registration deadline	Related substances
(3α,16α)-eburnamenin-14(15H)-one phosphate (1:1)	302-830-1	94134-60-8	31-May-2013	-
(3α,16α)-eburnamenine-14-carboxylic acid	248-651-1	27773-65-5	30-Nov-2010	-
(3α,4β,8α)-12,13-epoxytrichothec-9-ene-3,4,8,15-tetrol 4,15-diacetate 8-(3-methylbutyrate)	244-297-7	21259-20-1	31-May-2013	-
(3α,5β,12β)-3,12,14-trihydroxycard-20(22)-enolide	207-358-9	465-14-5	30-Nov-2010	-
(3α,5β,7α,12β)-3-(3-carboxy-1-oxopropoxy)-7,12-dihydroxycholan-24-oic acid	303-227-6	94159-47-4	31-May-2013	-
(3β)-3-acetoxyandrost-5-ene-17-carboxylic acid	257-197-3	51424-66-9	31-May-2013	-
(3β)-9,19-cyclolanost-24-en-3-yl 4-hydroxy-3-methoxycinnamate	244-285-1	21238-33-5	31-May-2013	-
(3β)-olean-12-ene-3,28-diol	208-890-4	545-48-2	30-Nov-2010	-
(3β)-stigmast-5-en-3-yl benzoate	217-597-0	1900-52-3	30-Nov-2010	-
(3β,16α)-3,16-dihydroxyolean-12-en-28-oic acid	208-112-3	510-30-5	30-Nov-2010	-
(3β,16α)-3-(β-D-glucopyranosyloxy)-16-hydroxyolean-12-en-28-oic acid	278-887-0	78285-90-2	31-May-2013	-
(3β,16β) -3-hydroxy-2'-methyl-5'H-pregna-5-eno[17,16-d]oxazole-20-one	919-368-7	-	31-May-2018	-
(3β,16β) -3-hydroxy-21-iodo-2'-methyl-5'H-pregna-5-eno[17,16-d]oxazole-20-one	921-206-5	-	31-May-2018	-
(3β,17β)-17-hydroxy-17-methylandrost-5-ene-3-ol propionate	262-514-3	60883-73-0	31-May-2013	-
(3β,17β)-17-methylandrost-5-ene-3,17-diyl bis(3-oxononanoate)	301-694-0	94030-88-3	31-May-2013	-
(3β,17ξ,20ξ,22E,24ξ)-stigmasta-5,22-dien-3-ol	279-536-4	80735-61-1	31-May-2013	-
(3β,19α,20α)-16,17-didehydro-10,11-dimethoxy-19-methyloxayohimban-16-carboxylic acid	238-327-8	14358-76-0	31-May-2013	-
(3β,19α,20α)-16,17-didehydro-10,11-dimethoxy-19-methyloxayohimban-16-carboxylic acid	284-240-3	84824-88-4	31-May-2013	-
(3β,21α)-8,14-secogammacera-8(26),14(27)-diene-3,21-diol	208-118-6	511-01-3	30-Nov-2010	-
(3β,22E,24R)-stigmasta-5,22-dien-3-ol	207-561-2	481-16-3	30-Nov-2010	-
(3β,22E,24ξ)-stigmasta-5,22-dien-3-ol	250-998-9	32345-19-0	31-May-2013	-
(3β,24S)-stigmast-5-en-3-ol	201-481-1	83-47-6	30-Nov-2010	-
(3β,24ξ)-stigmast-5-en-3-ol	242-776-5	19044-06-5	30-Nov-2010	-
(3β,24ξ)-stigmasta-5,22-dien-3-ol	278-402-2	76250-40-3	31-May-2013	-
(3β,4α)-3,23-dihydroxyolean-12-en-28-oic acid	207-369-9	465-99-6	30-Nov-2010	-
(3β,4α)-3-hydroxy-23-oxoolean-12-en-28-oic acid	211-353-7	639-14-5	31-May-2013	-
(3β,4α,16α)-3,16,23-trihydroxyolean-12-en-28-oic acid	258-265-5	52936-64-8	31-May-2013	-
(3β,5E,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol	252-891-2	36149-00-5	31-May-2013	-
(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-yl butyrate	250-567-5	31316-20-8	30-Nov-2010	-
(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,24,25-triol	254-749-5	40013-87-4	31-May-2013	-
(3β,5α)-3-[(6-O-β-D\-glucopyranosyl-β-D\-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide	243-616-7	20231-81-6	31-May-2013	-
(3β,5α)-4-methylstigmasta-7,24(28)-dien-3-ol	234-269-2	11040-28-1	30-Nov-2010	-
(3β,5α)-stigmastan-3-ol	201-479-0	83-45-4	30-Nov-2010	-
(3β,5β)-3,5,14,19-tetrahydroxycard-20(22)-enolide	209-211-4	560-54-3	30-Nov-2010	-
(3β,5β)-3,5,14-trihydroxy-19-oxocard-20(22)-enolide	200-626-6	66-28-4	30-Nov-2010	-
(3β,5β)-3-[(2,6-dideoxy-3,4-di-O-methyl-β-D\-ribo-hexopyranosyl)oxy]-5,14,19-trihydroxycard-20(22)-enolide	243-480-9	20045-09-4	30-Nov-2010	-
(3β,5β)-3-[(2,6-dideoxy-3-O-methyl-β-D\-ribo-hexopyranosyl)oxy]-5,14,19-trihydroxycard-20(22)-enolide	207-367-8	465-84-9	30-Nov-2010	-
(3β,5β)-3-[(2,6-dideoxy-4--O-β-D\-glucopyranosyl-β-D\-xylo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide	236-304-7	13289-20-8	31-May-2013	-
(3β,5β)-3-[(2,6-dideoxy-4-O-β-D\-glucopyranosyl-3-O-methyl-β-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide	209-210-9	560-53-2	30-Nov-2010	-
(3β,5β)-3-[(2,6-dideoxy-4-O-β-D\-glucopyranosyl-β-D\-ribo-hexopyranosyl)oxy]-5,14,19-trihydroxycard-20(22)-enolide	234-240-4	11006-14-7	31-May-2013	-
(3β,5β)-3-[(2,6-dideoxy-4-O-β-D\-glucopyranosyl-β-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide	230-381-0	7082-34-0	31-May-2013	-
(3β,5β)-3-[(2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14,19-trihydroxycard-20(22)-enolide	242-508-7	18695-02-8	30-Nov-2010	-
(3β,5β)-3-[(2,6-dideoxy-β-D\-ribo-hexopyranosyl)oxy]-14-hydroxy-5,19-[isopropylidenebis(oxy)]card-20(22)-enolide	254-537-2	39599-05-8	31-May-2013	-
(3β,5β)-3-[(2,6-dideoxy-β-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide	211-140-9	630-64-8	31-May-2013	-
(3β,5β)-3-[(6-deoxy-3-O-methyl-α-L\-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide	214-659-9	1182-87-2	31-May-2013	-
(3β,5β)-3-[(6-deoxy-4-O-β-D-glucopyranosyl-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide	236-749-7	13473-51-3	31-May-2013	-
(3β,5β)-3-[(6-deoxy-α-L-mannopyranosyl)oxy]-14-hydroxycard-20(22)-enolide	208-088-4	508-93-0	30-Nov-2010	-
(3β,5β)-3-[(O-β-D-glucopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14,19-trihydroxycard-20(22)enolide	253-563-1	37597-55-0	31-May-2013	-
(3β,5β)-3-[(O-β-D-glucopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide	251-439-1	33279-57-1	31-May-2013	-
(3β,5β)-3-[(O-β-D\-glucopyranosyl-(1→6)-O-D\-glucopyranosyl-(1→4)-6-deoxy-3-O-methyl-α-L\-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide	253-722-5	37933-66-7	31-May-2013	-

Showing 1,451 - 1,500 of 145,299 results.

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.

EU Privacy Disclaimer

Pre-registered substances

Pre-registered substances

Pre-registered substances

Further information

Database contains 145299 unique substances/entries.

EU Privacy Disclaimer